Recent Insider Transactions - Apellis Pharmaceuticals (NASDAQ: APLS)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

10/21/2025

Sell

$10.03

10,000

$100K

232,903

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

10/21/2025

Buy

$10.03

10,000

$100K

120,936

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

10/21/2025

Sell

$28.03

10,000

$280K

110,936

NASDAQ APLS Apellis Pharmaceuticals

Watson David O. / officer: General Counsel

10/16/2025

Sell

$25.22

5,000

$126K

113,730

NASDAQ APLS Apellis Pharmaceuticals

Dunlop A. Sinclair / director

10/10/2025

Sell

$23.72

31,092

$738K

3,837

NASDAQ APLS Apellis Pharmaceuticals

Dunlop A. Sinclair / director

09/30/2025

Sell

$22.58

31,092

$702K

33,979

NASDAQ APLS Apellis Pharmaceuticals

Dunlop A. Sinclair / director

09/19/2025

Sell

$22.95

31,092

$714K

68,908

NASDAQ APLS Apellis Pharmaceuticals

Watson David O. / officer: General Counsel

09/16/2025

Sell

$24.34

5,000

$122K

118,730

NASDAQ APLS Apellis Pharmaceuticals

Chopas James George / officer: VP/Chief Accounting Officer

09/15/2025

Sell

$24.19

189

$5K

53,468

NASDAQ APLS Apellis Pharmaceuticals

Watson David O. / officer: General Counsel

09/10/2025

Sell

$26.17

20,000

$523K

50,136

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

09/08/2025

Sell

$10.03

15,000

$150K

242,903

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

09/08/2025

Buy

$10.03

15,000

$150K

143,665

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

09/08/2025

Sell

$27.86

32,729

$912K

110,936

NASDAQ APLS Apellis Pharmaceuticals

Sullivan Timothy Eugene / officer: Chief Financial Officer

09/08/2025

Sell

$27.83

10,000

$278K

60,396

NASDAQ APLS Apellis Pharmaceuticals

Chopas James George / officer: VP/Chief Accounting Officer

09/02/2025

Sell

$28.08

548

$15K

53,657

NASDAQ APLS Apellis Pharmaceuticals

Boucher Kelley / officer: Chief People Officer

09/02/2025

Buy

$28.17

45,766

$1.289M

45,766

NASDAQ APLS Apellis Pharmaceuticals

Francois Cedric / director, officer: Chief Executive Officer

08/27/2025

Sell

$28.19

175,037

$4.934M

357,909

NASDAQ APLS Apellis Pharmaceuticals

Francois Cedric / director, officer: Chief Executive Officer

08/28/2025

Sell

$28.39

49,963

$1.418M

307,946